Odrick R. Rosas, School of Medicine, University of Puerto Rico Medical Sciences Campus, USA and his colleagues recently found that Src family kinase (SFK) inhibitor PP2 intervention greatly promoted the locomotor function recovery in the chronic stage after spinal cord trauma and simultaneously increased spared spinal tissue, but did not change the astrocytic response or infiltration of cells from the immune system.
↧